Clinical Trial Update: Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies [Phase 3]

View source ↗

Summary

This Phase 3 study evaluates TAS-102 in metastatic colorectal cancer refractory to standard chemotherapies and has completed with results posted in May 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-05-21